\documentclass[10pt,a4paper]{article}

% Packages
\usepackage{fancyhdr}           % For header and footer
\usepackage{multicol}           % Allows multicols in tables
\usepackage{tabularx}           % Intelligent column widths
\usepackage{tabulary}           % Used in header and footer
\usepackage{hhline}             % Border under tables
\usepackage{graphicx}           % For images
\usepackage{xcolor}             % For hex colours
%\usepackage[utf8x]{inputenc}    % For unicode character support
\usepackage[T1]{fontenc}        % Without this we get weird character replacements
\usepackage{colortbl}           % For coloured tables
\usepackage{setspace}           % For line height
\usepackage{lastpage}           % Needed for total page number
\usepackage{seqsplit}           % Splits long words.
%\usepackage{opensans}          % Can't make this work so far. Shame. Would be lovely.
\usepackage[normalem]{ulem}     % For underlining links
% Most of the following are not required for the majority
% of cheat sheets but are needed for some symbol support.
\usepackage{amsmath}            % Symbols
\usepackage{MnSymbol}           % Symbols
\usepackage{wasysym}            % Symbols
%\usepackage[english,german,french,spanish,italian]{babel}              % Languages

% Document Info
\author{Tblue1132}
\pdfinfo{
  /Title (patho-pharm-quiz-2.pdf)
  /Creator (Cheatography)
  /Author (Tblue1132)
  /Subject (Patho/pharm quiz 2 Cheat Sheet)
}

% Lengths and widths
\addtolength{\textwidth}{6cm}
\addtolength{\textheight}{-1cm}
\addtolength{\hoffset}{-3cm}
\addtolength{\voffset}{-2cm}
\setlength{\tabcolsep}{0.2cm} % Space between columns
\setlength{\headsep}{-12pt} % Reduce space between header and content
\setlength{\headheight}{85pt} % If less, LaTeX automatically increases it
\renewcommand{\footrulewidth}{0pt} % Remove footer line
\renewcommand{\headrulewidth}{0pt} % Remove header line
\renewcommand{\seqinsert}{\ifmmode\allowbreak\else\-\fi} % Hyphens in seqsplit
% This two commands together give roughly
% the right line height in the tables
\renewcommand{\arraystretch}{1.3}
\onehalfspacing

% Commands
\newcommand{\SetRowColor}[1]{\noalign{\gdef\RowColorName{#1}}\rowcolor{\RowColorName}} % Shortcut for row colour
\newcommand{\mymulticolumn}[3]{\multicolumn{#1}{>{\columncolor{\RowColorName}}#2}{#3}} % For coloured multi-cols
\newcolumntype{x}[1]{>{\raggedright}p{#1}} % New column types for ragged-right paragraph columns
\newcommand{\tn}{\tabularnewline} % Required as custom column type in use

% Font and Colours
\definecolor{HeadBackground}{HTML}{333333}
\definecolor{FootBackground}{HTML}{666666}
\definecolor{TextColor}{HTML}{333333}
\definecolor{DarkBackground}{HTML}{5C53E6}
\definecolor{LightBackground}{HTML}{F4F4FD}
\renewcommand{\familydefault}{\sfdefault}
\color{TextColor}

% Header and Footer
\pagestyle{fancy}
\fancyhead{} % Set header to blank
\fancyfoot{} % Set footer to blank
\fancyhead[L]{
\noindent
\begin{multicols}{3}
\begin{tabulary}{5.8cm}{C}
    \SetRowColor{DarkBackground}
    \vspace{-7pt}
    {\parbox{\dimexpr\textwidth-2\fboxsep\relax}{\noindent
        \hspace*{-6pt}\includegraphics[width=5.8cm]{/web/www.cheatography.com/public/images/cheatography_logo.pdf}}
    }
\end{tabulary}
\columnbreak
\begin{tabulary}{11cm}{L}
    \vspace{-2pt}\large{\bf{\textcolor{DarkBackground}{\textrm{Patho/pharm quiz 2 Cheat Sheet}}}} \\
    \normalsize{by \textcolor{DarkBackground}{Tblue1132} via \textcolor{DarkBackground}{\uline{cheatography.com/93559/cs/20648/}}}
\end{tabulary}
\end{multicols}}

\fancyfoot[L]{ \footnotesize
\noindent
\begin{multicols}{3}
\begin{tabulary}{5.8cm}{LL}
  \SetRowColor{FootBackground}
  \mymulticolumn{2}{p{5.377cm}}{\bf\textcolor{white}{Cheatographer}}  \\
  \vspace{-2pt}Tblue1132 \\
  \uline{cheatography.com/tblue1132} \\
  \end{tabulary}
\vfill
\columnbreak
\begin{tabulary}{5.8cm}{L}
  \SetRowColor{FootBackground}
  \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Cheat Sheet}}  \\
   \vspace{-2pt}Published 1st October, 2019.\\
   Updated 1st October, 2019.\\
   Page {\thepage} of \pageref{LastPage}.
\end{tabulary}
\vfill
\columnbreak
\begin{tabulary}{5.8cm}{L}
  \SetRowColor{FootBackground}
  \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Sponsor}}  \\
  \SetRowColor{white}
  \vspace{-5pt}
  %\includegraphics[width=48px,height=48px]{dave.jpeg}
  Measure your website readability!\\
  www.readability-score.com
\end{tabulary}
\end{multicols}}




\begin{document}
\raggedright
\raggedcolumns

% Set font size to small. Switch to any value
% from this page to resize cheat sheet text:
% www.emerson.emory.edu/services/latex/latex_169.html
\footnotesize % Small font.

\begin{multicols*}{3}

\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Anti Microbial Drugs Names}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{Penicillins} \tn 
% Row Count 1 (+ 1)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{Cephalosporins} \tn 
% Row Count 2 (+ 1)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{Macrolides} \tn 
% Row Count 3 (+ 1)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{Fluoroquinolones} \tn 
% Row Count 4 (+ 1)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{Glycopeptide Antibiotic} \tn 
% Row Count 5 (+ 1)
% Row 5
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{Sulfonamides and Trimethoprim} \tn 
% Row Count 6 (+ 1)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Penicilins}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Drug Name}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Penicillin G, Penicillin V, Amoxicillin, Ampicillin} \tn 
% Row Count 3 (+ 3)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Common Name}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Almost all end in "cillin"} \tn 
% Row Count 5 (+ 2)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Indications (why we use the drug)}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Pneumonia \{\{nl\}\} Meningitis \{\{nl\}\} Endocarditis \{\{nl\}\} Pharyngitis \{\{nl\}\} Syphilis \{\{nl\}\} Prophylaxis- against bacterial endocarditis in at-risk clients prior to dental procedures} \tn 
% Row Count 10 (+ 5)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Potential Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Diarrhea, epigastric distress, nausea, vomiting, rash, pain at IM injection site, phlebitis at IV injection site} \tn 
% Row Count 14 (+ 4)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Life threatening Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Allergic reaction(anaphylaxisis) \{\{nl\}\} {\emph{amoxicillin specific}} : seizures (high doses), clostridium difficile (CDIF) assoc. diarrhea} \tn 
% Row Count 18 (+ 4)
% Row 5
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Nursing Implications}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}-Ask about allergies to penicillins \{\{nl\}\} -monitor for allergic reaction \{\{nl\}\} assess for infection before and after therapy \{\{nl\}\} -obtain specimen for culture BEFORE therapy \{\{nl\}\} -monitor for bowl function for CDIF and report to PCP \{\{nl\}\} -monitor kidney function(nephrotic) \{\{nl\}\} -if PT is taking PO(by mouth)penicillins advise PT to take with food and finish entire course of antibiotic , even if symptoms are resolved} \tn 
% Row Count 29 (+ 11)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{mechanism of action}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Binds to bacterial cell wall membrane, causing a cell death . Known as "beta-lactam"} \tn 
% Row Count 32 (+ 3)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Penicilins (cont)}}  \tn
% Row 7
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Notes}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}1\textasciicircum{}st\textasciicircum{} class if antibiotics \{\{nl\}\} high levels of antibiotic resistance to early penicillins \{\{nl\}\}} \tn 
% Row Count 4 (+ 4)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Fluoroquinolines}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Drug Names}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Ciprofloxacin \{\{nl\}\} Ofloxacin \{\{nl\}\} Moxifloxacin \{\{nl\}\} Levofloxacin \{\{nl\}\} Norfloxacin} \tn 
% Row Count 3 (+ 3)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Name Commonality}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Almost all end in "oxacin"} \tn 
% Row Count 5 (+ 2)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Indication}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}-UTI \{\{nl\}\} -respiratory infections \{\{nl\}\} -GI tract infections \{\{nl\}\} -Infections of bones, joints, skin, soft tissues \{\{nl\}\} -Anthrax prophylaxis in those that have inhaled anthrax spores} \tn 
% Row Count 11 (+ 6)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Potential Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Dizziness, headache, insomnia, diarrhea, nausea, Achilles' tendon rupture, phototoxicity (severe sunburn)} \tn 
% Row Count 15 (+ 4)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Life threatening Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Elevated intracranial pressure(ICP) \{\{nl\}\} seizures \{\{nl\}\} suicidal thoughts \{\{nl\}\} hepatoxicity \{\{nl\}\} Clostriudim Difficule (CDIF) assoc. diarrhea \{\{nl\}\} hypersensitivity reaction \{\{nl\}\} SJS \{\{nl\}\} Torsade de Pointes} \tn 
% Row Count 21 (+ 6)
% Row 5
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Nursling Implications}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}-Monitor for allergic reaction \{\{nl\}\} -Assess for infection before and after therapy \{\{nl\}\} -Obtain specimen for culture before therapy \{\{nl\}\} -Monitor for skin rash and SJS \{\{nl\}\} -Monitor bowel function for CDIF assoc. diarrhea \{\{nl\}\} -Advise PT to observe and report swelling, pain, or inflammation at Achilles' tendon side and to stop taking med \{\{nl\}\} -Teach PT to avoid prolonged sun exposure} \tn 
% Row Count 31 (+ 10)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Fluoroquinolines (cont)}}  \tn
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Mechanism of Action}}} \tn 
% Row Count 1 (+ 1)
% Row 7
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{Inhibit enzymes necessary for bacterial DNA replication (DNA gyrase and topoisomerase IV)} \tn 
% Row Count 3 (+ 2)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Cephalosporins}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Drug Name}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}1\textasciicircum{}st\textasciicircum{} gen: Cephalexin \{\{nl\}\} 2\textasciicircum{}nd\textasciicircum{} gen: Cefaclor \{\{nl\}\} 3\textasciicircum{}rd\textasciicircum{} gen:Ceftraixone \{\{nl\}\} 4\textasciicircum{}th\textasciicircum{} gen: Cefepime \{\{nl\}\} 5\textasciicircum{}th\textasciicircum{} gen: Ceftaroline} \tn 
% Row Count 4 (+ 4)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Name Commonaility}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}All start with "cef"} \tn 
% Row Count 6 (+ 2)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{ Indications}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}{\emph{Note: dependent on generation}} \{\{nl\}\} -skin and skin structure infections \{\{nl\}\} -bone and joint infections \{\{nl\}\} -complicated and uncomplicated UTIs \{\{nl\}\} -Gynecological infections \{\{nl\}\} -lower respiratory tract infections \{\{nl\}\} - intra-abdominal infections \{\{nl\}\} -septicemia \{\{nl\}\} -meningitis \{\{nl\}\} -Otitis Media \{\{nl\}\} -Perioperative (surgery) prophylaxis} \tn 
% Row Count 15 (+ 9)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Potential Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Pain at IM injection site \{\{nl\}\} phlebitis at IV injection site \{\{nl\}\} rash} \tn 
% Row Count 18 (+ 3)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Life threatening Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Seizures(at high doses), CDIF associated diarrhea, allergic reaction (anaphylaxis), SJS(Steven-Johnson Syndrome)} \tn 
% Row Count 22 (+ 4)
% Row 5
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Nursing Implications}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}-Ask about Allergies both Cephalosporins and Penicillins \{\{nl\}\} -monitor for allergic reactions \{\{nl\}\} -assess for infection before and after therapy \{\{nl\}\} -Obtain specimen for culture before therapy \{\{nl\}\} -Monitor bowel fucntion for CDIF assoc. diarrhea \{\{nl\}\} -Monitor for skin rash frequently and discontinue at 1\textasciicircum{}st\textasciicircum{} sign of use(SJS) \{\{nl\}\} -Monitor for kidney fucntion(nephrotic)} \tn 
% Row Count 32 (+ 10)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Cephalosporins (cont)}}  \tn
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Mechanism of Action}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Bind to the bacterial cell wall membrane causing cell death . (Aka beta-lactam)} \tn 
% Row Count 3 (+ 3)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{Note: each generation is likely to reach cerebrospinal fluid(CSF), less susceptible to antibiotic resistance and more effective against gram-negative organisms. \newline  \newline Common-class because they are broad-spectrum , well tolerated, and easy to administer.}  \tn 
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{{\bf{Sulfonamides \& Trimethoprim}}}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Drug Names}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}\seqsplit{Trimethoprim-sulfamethoxazole} \{\{nl\}\} Sulfadiazine \{\{nl\}\} Trimethoprim} \tn 
% Row Count 3 (+ 3)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Name Commonailty}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}N/A} \tn 
% Row Count 5 (+ 2)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Indications}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}-UTI \{\{nl\}\} -Otitis Media \{\{nl\}\} -Chancroid \{\{nl\}\} -Pertussis (Whooping cough) -\{\{nl\}\} -Shingellosis \{\{nl\}\} -Pneumocystic jirovecii pneumonia \{\{nl\}\} -Bronchitis} \tn 
% Row Count 10 (+ 5)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Potential Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Nausea, vomiting, rash, phlebitis} \tn 
% Row Count 12 (+ 2)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Life threatening Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}CDIF assoc diarrhea\{\{nl\}\} Hepatic Necrosis \{\{nl\}\}erythema multiforme \{\{nl\}\} toxic epidermal necrolysis \{\{nl\}\} Agranulocytosis \{\{nl\}\} Aplastic Anemia \{\{nl\}\} Hypersensitivity reaction \{\{nl\}\} SJS} \tn 
% Row Count 18 (+ 6)
% Row 5
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Nursing Implications}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}-Assess for infection before and after therapy \{\{nl\}\} -Obtain Specimen for culture before therapy \{\{nl\}\} -Monitor IV site closely \{\{nl\}\} -Monitor for allergic reaction \{\{nl\}\} -Do not administer to PT w/ allergy to sulfa drugs, thiazide diuretics, loop diuretics, solfonylurea-type oral hypoglycemics(glipizide) \{\{nl\}\} -Assess for rash and stop at sign of SJS \{\{nl\}\} -Encourage liberal fluid intake \{\{nl\}\} -Monitor urine output \{\{nl\}\} -DO NOT give to women who are pregnant or breastfeeding, or to infants younger than 2 months \{\{nl\}\} -Monitor K+ levels (hyperkalemia) \{\{nl\}\} -Obtain regular CBC to monitor for hematologic disorders \{\{nl\} -Monitor bowel fucntion for CDIF assoc diarrhea and provide to PCP} \tn 
% Row Count 34 (+ 16)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{{\bf{Sulfonamides \& Trimethoprim}} (cont)}}  \tn
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Mechanism of Action}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Inhibits bacterial growth by stopping synthesis of tetrahydrofolate, which is essential for DNA, RNA, and protein production} \tn 
% Row Count 4 (+ 4)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Macrolides}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Drug Name}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Erythromycin \{\{nl\}\} Azithromycin\{\{nl\}\} Clarithromycin} \tn 
% Row Count 3 (+ 3)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Name Commonalitiy}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Almost all end in "mycin"} \tn 
% Row Count 5 (+ 2)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Indications}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Alternative for PTs who have a penicillin allergy \{\{nl\}\} Legionnaries' Disease\{\{nl\}\} Pertuesis(whooping cough) and other respiratory infections \{\{nl\}\} acute diphtheria \{\{nl\}\} chlamydial infections \{\{nl\}\} Pneumonia (due to Mycoplasma pneumoniae) \{\{nl\}\} Streptococcal infections} \tn 
% Row Count 12 (+ 7)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Potential Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Abdominal Pain\{\{nl\}\} Diarrhea \{\{nl\}\} Nausea \{\{nl\}\} Vomitting} \tn 
% Row Count 15 (+ 3)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Life-Threatening Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Ventricular arrhythmias \{\{nl\}\} Torases de Pointes\{\{nl\}\} Hepatoxicicity\{\{nl\}\} CDIF assoc. diarrhea\{\{nl\}\} acute generalized exanthermatous pustulosis \{\{nl\}\} drug reaction with eosinophilia and systemic symptoms(DRESS) \{\{nl\}\} SJS \{\{nl\}\} toxic epidermal necrolysis} \tn 
% Row Count 22 (+ 7)
% Row 5
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Nursing Implications}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}-Monitor for allergic reactions \{\{nl\}\} -Assess for infection before and after therapy \{\{nl\}\} -Obtain specimen for culture before therapy \{\{nl\}\} -Monitor for skin rash frequently and discontinue at first sign of SJS \{\{nl\}\} -May cause increase in certain labs (serum bilirubin, AST,ALT,LDH, alkaline  phophatase) \{\{nl\}\}-administer with meals \{\{nl\}\} -monitor for CDIF assoc. diarrhea and report to PCP \{\{nl\}\} -monitor for ototoxicity \{\{nl\}\} -monitor for dysrhythmias \{\{nl\}\} -Erythromycin inhibits metabolism if antihistamines, theophylline, Carbamazepine, warfarin, and digoxin} \tn 
% Row Count 36 (+ 14)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Macrolides (cont)}}  \tn
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Mechanism of Action}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Inhibits bacterial protein synthesis} \tn 
% Row Count 2 (+ 2)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{{\bf{Glycopeptide Antibiotic}}}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Drug Names}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Vancomycin} \tn 
% Row Count 2 (+ 2)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Name Commonality}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}N/A} \tn 
% Row Count 4 (+ 2)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{indications}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}-Treatment of potential life-threatening infections when less toxic antiFestive are contraindicated \{\{nl\}\} -Particularly useful in staphylococcal infections (MRSA, methicillin resistant staphylococcus aureus) \{\{nl\}\} -Endocarditis \{\{nl\}\} -Meningitis \{\{nl\}\} -Pneumonia \{\{nl\}\} -Septicemia \{\{nl\}\} -Soft tissue infections in Pt who have allergies to penicillins or infections w/penicillin resistance} \tn 
% Row Count 14 (+ 10)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Potential Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Nephrotoxicity, phlebitis, Nausea, Vomitting, Hypotension, Ototoxicity} \tn 
% Row Count 17 (+ 3)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Life Threatening Side Effects}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Hypersensitivity reaction(Anaphylaxis)} \tn 
% Row Count 19 (+ 2)
% Row 5
\SetRowColor{white}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Nursing Implications}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}-Assess for infection before and after therapy \{\{nl\}\} -Obtain specimen for culture before therapy \{\{nl\}\} -Monitor IV site closely (vanxomycin very irritating) and rotate infusion site \{\{nl\}\} -Monitor BP during therapy for hypotension \{\{nl\}\} -Monitor for otoxcicity (toxic to ear and auditory nerve) \{\{nl\}\} -Monitor for nephrotoxicity \{\{nl\}\} -Monitor for allergic reaction} \tn 
% Row Count 28 (+ 9)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{5.377cm}}{{\bf{Mechanism of Action}}} \tn 
\mymulticolumn{1}{x{5.377cm}}{\hspace*{6 px}\rule{2px}{6px}\hspace*{6 px}Binds to bacterial cell wall, resulting in cell death} \tn 
% Row Count 31 (+ 3)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}


% That's all folks
\end{multicols*}

\end{document}